nach oben

Current Bladder Dysfunction Reports

Erschienen in:

01.06.2015 | BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Comparison of Transurethral Surgical Methods

verfasst von: Malte Rieken, Alexander Bachmann

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Transurethral surgical techniques are an integral part of the urologists’ armamentarium for the treatment of lower urinary tract symptoms caused by benign prostate enlargement. Besides monopolar transurethral resection of the prostate (M-TURP), which can be regarded as the gold standard and reference technique, several established surgical alternatives are available. Bipolar TURP offers comparable functional outcomes to M-TURP at a lower rate of perioperative morbidity. Modifications of the bipolar technique such as vaporization or enucleation show promising results but need further investigation. Fewer complications and comparable long-term outcomes are found after holmium laser enucleation of the prostate (HoLEP) when compared with M-TURP. GreenLight laser vaporization (GLV) of the prostate is also associated with fewer perioperative complications than TURP and comparable short-term outcomes. Thulium laser enucleation of the prostate resembles HoLEP but still lacks long-term results from prospective randomized trials. The same is true for diode lasers, which need to be further investigated in high-quality studies to acquire sufficient evidence.

1.••

Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–40. Summary of the latest EAU Guideline on male LUTS.PubMedCrossRef

Hartung R, Mauermayer W, Beck F, Karcher G. The controlled TUR: a new method for the measurement of intraoperative blood-loss during TUR (author’s transl). Der Urologe Ausg A. 1976;15(5):254–7.PubMed

Mauermayer W. Indications for surgical treatment of prostatic adenoma. Med Klin. 1978;73(40):1363–70.PubMed

Jonas U, Gabouev AI, Herrmann TR, Hofner K, Michel MC, Alschibaja M, et al. Benign prostate hyperplasia. Der Urologe Ausg A. 2006;45 Suppl 4:134–44.PubMedCrossRef

Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246–9.PubMedCrossRef

Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009;56(5):798–809.PubMedCrossRef

Costello AJ, Johnson DE, Bolton DM. Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med. 1992;12(2):121–4.PubMedCrossRef

Muschter R, Hessel S, Hofstetter A, Keiditsch E, Rothenberger KH, Schneede P, et al. Interstitial laser coagulation of benign prostatic hyperplasia. Der Urologe Ausg A. 1993;32(4):273–81.PubMed

9.••

Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2014. Important and comprehensive up to date meta-analysis on variuos transurethral surgical methods.

10.

Giulianelli R, Albanesi L, Attisani F, Gentile BC, Vincenti G, Pisanti F, et al. Comparative randomized study on the efficaciousness of endoscopic bipolar prostate resection versus monopolar resection technique. 3 year follow-up. Arch Ital Urol Androl Organo Ufficiale Soc Ital Ecografia Urol Nefrol Associazione Ric Urol. 2013;85(2):86–91.

11.

Autorino R, Damiano R, Di Lorenzo G, Quarto G, Perdona S, D’Armiento M, et al. Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol. 2009;55(4):922–9.PubMedCrossRef

12.

Xie CY, Zhu GB, Wang XH, Liu XB. Five-year follow-up results of a randomized controlled trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Yonsei Med J. 2012;53(4):734–41.PubMedCentralPubMedCrossRef

13.••

Mamoulakis C, Schulze M, Skolarikos A, Alivizatos G, Scarpa RM, Rassweiler JJ, et al. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol. 2013;63(4):667–76. Important multi-center RCT on monopolar vs. bipolar TURP.PubMedCrossRef

14.

Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis. J Endourol Endourol Soc. 2014;28(9):1107–14.CrossRef

15.

Issa MM. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol Endourol Soc. 2008;22(8):1587–95.CrossRef

16.

Akman T, Binbay M, Tekinarslan E, Tepeler A, Akcay M, Ozgor F, et al. Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: a prospective randomized comparative study. BJU Int. 2013;111(1):129–36.PubMedCrossRef

17.•

Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivizatos G, et al. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013;112(1):109–20. Interesting analysis of the impact of mono- and bipolar TURP on sexual function.PubMedCrossRef

18.

Gilling PJ, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol. 1996;10(5):459–61.PubMedCrossRef

19.

Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998;12(5):457–9.PubMedCrossRef

20.

Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007;52(5):1456–63.PubMedCrossRef

21.

Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006;175(5):1817–21.PubMedCrossRef

22.

Eltabey MA, Sherif H, Hussein AA. Holmium laser enucleation versus transurethral resection of the prostate. Can J Urol. 2010;17(6):5447–52.PubMed

23.•

Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109(3):408–11. Long-term data of an RCT on HoLEP and TURP.PubMedCrossRef

24.

Gupta N, Sivaramakrishna KR, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int. 2006;97(1):85–9.PubMedCrossRef

25.

Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol Endourol Soc. 2004;18(2):189–91.CrossRef

26.

Mavuduru RM, Mandal AK, Singh SK, Acharya N, Agarwal M, Garg S, et al. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int. 2009;82(2):130–5.PubMedCrossRef

27.

Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2004;172(5 Pt 1):1926–9.PubMedCrossRef

28.

Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl):S87–90.PubMedCrossRef

29.

Neill MG, Gilling PJ, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR, et al. Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology. 2006;68(5):1020–4.PubMedCrossRef

30.

Rigatti L, Naspro R, Salonia A, Centemero A, Ghezzi M, Guazzoni G, et al. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology. 2006;67(6):1193–8.PubMedCrossRef

31.

Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170(4 Pt 1):1270–4.PubMedCrossRef

32.

Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006;50(3):569–73.PubMedCrossRef

33.

Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol. 2004;172(3):1012–6.PubMedCrossRef

34.

Chen YB, Chen Q, Wang Z, Peng YB, Ma LM, Zheng DC, et al. A prospective, randomized clinical trial comparing plasmakinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year followup. J Urol. 2013;189(1):217–22.PubMedCrossRef

35.

Fayad AS, Sheikh MG, Zakaria T, Elfottoh HA, Alsergany R. Holmium laser enucleation versus bipolar resection of the prostate: a prospective randomized study. Which to choose? J Endourol Endourol Soc. 2011;25(8):1347–52.CrossRef

36.

Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology. 2012;79(4):869–74.PubMedCrossRef

37.•

Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol. 2012;188(1):216–21. Data of the first study comparing HoLEP and GLV.PubMedCrossRef

38.

Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol Endourol Soc. 2013;27(5):604–11.CrossRef

39.

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97.PubMedCrossRef

40.

Elshal AM, Elkoushy MA, El-Nahas AR, Shoma AM, Nabeeh A, Carrier S, et al. Green Light Laser (XPS) photoselective vapo-enucleation of the prostate versus holmium laser enucleation of the prostate for treatment of symptomatic benign prostate hyperplasia: a randomized controlled study. J Urol. 2014.

41.

Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2006;175(4):1428–32.PubMedCrossRef

42.

Tyson MD, Lerner LB. Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol Endourol Soc. 2009;23(8):1343–6.CrossRef

43.

Yip SK, Chan NH, Chiu P, Lee KW, Ng CF. A randomized controlled trial comparing the efficacy of hybrid bipolar transurethral vaporization and resection of the prostate with bipolar transurethral resection of the prostate. J Endourol Endourol Soc. 2011;25(12):1889–94.CrossRef

44.

Zhang SY, Hu H, Zhang XP, Wang D, Xu KX, Na YQ, et al. Efficacy and safety of bipolar plasma vaporization of the prostate with “button-type” electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chin Med J. 2012;125(21):3811–4.PubMed

45.

Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P. Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: ‘the better choice’ in benign prostatic hyperplasia? BJU Int. 2010;106(11):1695–9.PubMedCrossRef

46.•

Zhao Z, Zeng G, Zhong W, Mai Z, Zeng S, Tao X. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol. 2010;58(5):752–8. Important RCT on bipolar enucleation vs. TURP.PubMedCrossRef

47.

Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W, et al. Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol. 2013;189(4):1427–31.PubMedCrossRef

48.

Kan CF, Tsu HL, Chiu Y, To HC, Sze B, Chan SW. A prospective study comparing bipolar endoscopic enucleation of prostate with bipolar transurethral resection in saline for management of symptomatic benign prostate enlargement larger than 70 g in a matched cohort. Int Urol Nephrol. 2014;46(3):511–7.PubMedCrossRef

49.

McAllister WJ, Gilling PJ. Vaporization of the prostate. Curr Opin Urol. 2004;14(1):31–4.PubMedCrossRef

50.

Te AE. The development of laser prostatectomy. BJU Int. 2004;93(3):262–5.PubMedCrossRef

51.

Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol. 2012;61(3):600–7.PubMedCrossRef

52.

Rieken M, Bonkat G, Muller G, Wyler S, Mundorff NE, Puschel H, et al. The effect of increased maximum power output on perioperative and early postoperative outcome in photoselective vaporization of the prostate. Lasers Surg Med. 2013;45(1):28–33.PubMedCrossRef

53.

Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology. 2008;71(2):247–51.PubMedCrossRef

54.•

Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010;58(3):349–55. RCT on GLV vs. TURP with the longest currently available follow-up.

55.

Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010;105(7):964–9.PubMedCrossRef

56.

Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011;60(4):734–9.PubMedCrossRef

57.

Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012;61(6):1165–73.PubMedCrossRef

58.

Pereira-Correia JA, de Moraes Sousa KD, Santos JB, de Perpetuo Morais D, Lopes-da-Silva LF, Krambeck RL, et al. GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012;110(8):1184–9.PubMedCrossRef

59.

Kumar A, Vasudeva P, Kumar N, Nanda B, Jha SK, Mohanty NK. A prospective randomized comparative study of monopolar transurethral resection of prostate (TURP), bipolar TURP and photoselective vaporization of prostate in patients presenting with benign prostatic obstruction—a single center experience. J Endourol Endourol Soc. 2013.

60.

Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2014.

61.••

Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial—the GOLIATH study. Eur Urol. 2014;65(5):931–42. Important multi-center RCT on GLV vs. TURP.PubMedCrossRef

62.

Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol. 2012;62(2):315–23.PubMedCrossRef

63.

Elshal AM, Elmansy HM, Elhilali MM. Two laser ablation techniques for a prostate less than 60 ml: lessons learned 70 months after a randomized controlled trial. Urology. 2013.

64.•

Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol. 2011;186(3):977–81. Analysis of complications after PVP in high-risk patients.PubMedCrossRef

65.

Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2007;51(4):1031–8. discussion 1038–1041.PubMedCrossRef

66.

Tao W, Xue B, Zang Y, Sun C, Yang D, Zhang Y, et al. The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci. 2013;28(4):1151–7.PubMedCrossRef

67.

Spernat DM, Hossack TA, Woo HH. Photoselective vaporization of the prostate in men taking clopidogrel. Urol Ann. 2011;3(2):93–5.PubMedCentralPubMedCrossRef

68.

Woo HH, Hossack TA. Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking coumadin. Urology. 2011;78(1):142–5.PubMedCrossRef

69.

Karatas OF, Alkan E, Horasanli K, Luleci H, Sarica K. Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol Off J Braz Soc Urol. 2010;36(2):190–7.CrossRef

70.

Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR, et al. Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol. 2012;61(2):317–25.PubMedCrossRef

71.

Bach T, Xia SJ, Yang Y, Mattioli S, Watson GM, Gross AJ, et al. Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol. 2010;28(2):163–8.PubMedCrossRef

72.

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol. 2008;53(2):382–9.PubMedCrossRef

73.

Yan H, Ou TW, Chen L, Wang Q, Lan F, Shen P, et al. Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol Off J Jpn Urol Assoc. 2013;20(5):507–12.

74.

Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP, et al. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int. 2013;111(4):633–7.PubMedCrossRef

75.

Yang Z, Wang X, Liu T. Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology. 2013;81(2):396–400.PubMedCrossRef

76.

Netsch C, Stoehrer M, Bruning M, Gabuev A, Bach T, Herrmann TR, et al. Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy. World J Urol. 2013.

77.

Hruby S, Sieberer M, Schatz T, Jones N, Zimmermann R, Janetschek G, et al. Eraser laser enucleation of the prostate: technique and results. Eur Urol. 2013;63(2):341–6.PubMedCrossRef

78.

Lusuardi L, Myatt A, Sieberer M, Jeschke S, Zimmermann R, Janetschek G. Safety and efficacy of Eraser laser enucleation of the prostate: preliminary report. J Urol. 2011;186(5):1967–71.PubMedCrossRef

79.

Xu A, Zou Y, Li B, Liu C, Zheng S, Li H, et al. A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol Endourol Soc. 2013;27(10):1254–60.CrossRef

80.

Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A. Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology. 2014;84(3):526–32.PubMedCrossRef

81.

Shaker HS, Shoeb MS, Yassin MM, Shaker SH. Quartz head contact laser fiber: a novel fiber for laser ablation of the prostate using the 980 nm high power diode laser. J Urol. 2012;187(2):575–9.PubMedCrossRef

Titel: Comparison of Transurethral Surgical Methods
verfasst von: Malte Rieken
Alexander Bachmann
Publikationsdatum: 01.06.2015
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 2/2015
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-015-0294-7

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Comparison of Transurethral Surgical Methods

Abstract

Neu im Fachgebiet Urologie

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Darf man die Behandlung eines Neonazis ablehnen?

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Evaluation of Pelvic Organ Prolapse With Medical Imaging

The Rezūm System: Minimally Invasive Treatment for BPH Using Water Vapor (Steam): Why Consider It?

Differential Response to Medical Therapy for Male Lower Urinary Tract Symptoms

Rectal Cancer-Associated Urinary Dysfunction: a Review

Urodynamics in Male Lower Urinary Tract Symptoms

Current Strategies for Prevention and Management of Stem Cell Transplant-Related Urinary Tract and Voiding Dysfunction

Neu im Fachgebiet Urologie

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Darf man die Behandlung eines Neonazis ablehnen?

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Urologie